We evaluated (1) endothelial function (FMD, ICAM-1 and VCAM-1) cross-sectionally in subjects with (MS+) and without (MS-) metabolic syndrome who were at increased risk for cardiovascular disease due to either HNBP and/or IGR, and (2) examined in a subgroup of subjects the effects of 24-week lifestyle modification on endothelial function. MS components, FMD by Doppler ultrasound, ICAM-1 and VCAM-1 by fasting blood samples were assessed. All of the endothelial functions were similar between MS-and MS+. Although waist circumference, blood pressure, and fasting glucose showed improvements, endothelial function remained unchanged following the intervention. The results showed that in our subject population, MS does not reduce endothelial function, and our 24-week lifestyle modification programme did not result in an improvement in endothelial function in MS+ despite the improvements in some MS components.
Introduction
The endothelium plays a crucial role in the regulation of vasomotor tone, homeostasis, thrombosis and inflammation because of its unique anatomical position between blood and tissues, and also its ability to generate vasoactive substances such as NO. 1 The imbalance between those endothelium-derived vasoactive substances results in endothelial dysfunction. Dysfunction in the endothelium may be an early stage in the atherosclerotic CVD continuum, often preceding a clinically overt atherosclerosis. Consequently, the assessment of endothelial function could be used for a marker of early atherosclerotic CVD risk.
FMD of a conduit artery that reflects mainly the bioavailability of NO has been used as a marker of endothelial function. 2, 3 Interestingly, besides its vasodilatory effects, NO also inhibits leukocyte adhesion to the vascular endothelium. 4, 5 Leukocyte adhesion is an important step in the initiation of atherosclerosis. In addition to being key players for the development of atherosclerosis legion, adhesion molecules such as ICAM-1 and VCAM-1 that mediate adhesion and subsequent migration of leukocytes into the arterial wall are also used as markers for endothelial function. 6, 7 Accordingly, the assessment of these two related but distinct endothelial functions may shed light on a more comprehensive view of vascular health (atherosclerotic risk) than an assessment of only one of them.
The MS, a constellation of CVD risk factors, has been shown to directly increase atherosclerotic CVD. 8 As both endothelial function and MS are associated with CVD, endothelial function is expected to be reduced in subjects with MS. However, examination of endothelial function in MS has led to conflicting results. [9] [10] [11] [12] [13] [14] [15] [16] [17] In a related manner, exercise is known to benefit endothelial function, particularly in individuals with CVD. 18 Although lifestyle modification is advocated as a first-line therapy for the treatment of MS, 8 there have been few studies that examined an effect of this intervention on endothelial function in subjects with MS.
Therefore, the purpose of this study was to test the hypothesis that the presence of MS would be associated with reduced endothelial function and that this effect of MS could be minimised by a 24-week lifestyle modification program. We first evaluated endothelial function (brachial artery FMD, ICAM-1, and VCAM-1) in subjects with and without MS who were at increased risk for CVD (had either HNBP and/or IGR). Subsequently, these markers were evaluated in a subgroup of participants before and following a 24-week lifestyle modification programme.
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Methods Participants
This study was a part of the SNAC study whose purpose was to evaluate the effectiveness of lifestyle modification prescribed by a family physician (aerobic exercise and Mediterranean-style diet) on cardiovascular structure and function in those who had an increased cardiovascular risk(s) (HNBP and/or IGR). For the cross-sectional study, 89 subjects (40 male and 49 female, 53.5±9.3 years) with either HNBP (SBP 130 to 139 and/or DBP 85 to 90 mmHg), IGR (IFG 6.1 to 7.0 mmol/L and/or IGT 7.8 to 11.0 mmol/L following an oral glucose tolerance test), or both were studied. For the intervention study, a subgroup of 52 participants (27 male and 25 female, 53.9±8.6 years, age range 36-80) was studied. All participants had no overt cardiovascular disease and none of them were taking any hypertension or diabetes medication. Eight subjects in the intervention study were on a cholesterol-lowering medication before starting the study and were allowed to continue their drug regimen throughout the study period. All patients were referred from their own family physician for the purpose of this study. The study was approved by The University of Western Ontario Research Ethics Board for Health Sciences Research Involving Human Subjects and all subjects gave written informed consent prior to participation.
Definition of metabolic syndrome
MS was defined on the basis of the AHA-NHLBI guidelines by the presence of three or more of the following criteria: (1) waist circumference ≥ 102 cm in men and ≥ 88 cm in women; (2) triglyceride levels ≥ 1.69 mmol/L; (3) HDL cholesterol levels < 1.04 mmol/L in men and < 1.29 mmol/L in women; (4) fasting plasma glucose levels ≥ 5.60 mmol/L; and (5) SBP ≥130 mmHg and/or DBP > 85 mmHg. 8 
Study design
For the cross-sectional study, participants were studied in the early morning following a complete overnight fast including caffeine. The following measurements were included: blood chemistry (total cholesterol, HDL cholesterol, LDL cholesterol, tryglycerides, glucose, insulin, HbA 1 c and CRP) by routine laboratory methods, HOMA-IR, 19 anthropometrics (height, weight, waist circumference), resting BP, endothelial function of brachial artery and intima-media thickness of carotid artery by a Doppler ultrasound device, blood-borne markers of endothelial function (ICAM-1 and VCAM-1), and exercise capacity by a treadmill exercise test. For the intervention study, the above measurements were repeated following 24 weeks of the SNAC intervention. Each test was conducted in a temperature-controlled room and at the same time of day for each subject.
Brachial artery endothelial function
Endothelial function of the brachial artery was assessed by FMD (an endothelium-dependent vasodilation), and NMD (an endothelium-independent vasodilation) based on a previously published guideline. 20 After 10 minutes of supine rest, the right brachial artery was examined above the antecubital fossa by a Doppler ultrasound device with a linear array multifrequency transducer (VingMed System 5, GE Ultrasound A/S, Horton, Norway). All scans were performed by the same investigator and made under similar conditions. The longitudinal B-mode diameter of the brachial artery, defined as the distance between the media and adventitia interface of the near wall and far wall, was measured at the onset of R wave of the electrocardiogram. Gain settings were optimised to identify the interface between the lumen and arterial wall, and all images were recorded to S-VHS tape for later offline analysis. The images of the brachial artery were analysed from the stored images using callipers with a resolution of 0.03 mm. For each image, the average of three diameter measurements was used. Reactive hyperaemia was induced by inflation of a blood pressure cuff on the proximal forearm to a level of 50 mmHg above each subject's SBP for 5 minutes. Brachial artery diameter measurements were performed before and 45 to 75 seconds following the cuff deflation. After a 10-minute rest, NMD was induced by a sublingual spray of nitroglycerin (0.4 mg). If the participant declined, had SBP < 100 mmHg, or had a previous adverse reaction to nitrates, this part of the measurement was omitted (18 participants in the cross-sectional study and seven in the intervention study). Brachial artery diameter measurements were repeated 180 to 210 seconds following the nitroglycerin spray. FMD and NMD were expressed as the relative diameter change in the brachial artery diameter during reactive hyperaemia. The coefficients of variation for our brachial artery diameter, FMD and NMD measurements were 3.7%, 15.2% and 16.6%, respectively.
Carotid artery intima-media thickness
cIMT was assessed by the same ultrasound device. All scans were performed by the same investigator and made under similar conditions. The longitudinal B-mode images of the carotid artery diameter and cIMT were assessed while subjects were in a supine position. Both the diameter and cIMT were examined at a straight portion of the artery 1-2 cm proximal to the bifurcation. Carotid artery diameter was defined as the distance between the lumen-intima interface of the near wall and far wall. cIMT was defined as the distance between the lumen-intima interface and media-adventitia interface of the far wall. The coefficient of variation for our IMT measurement was 4.1%.
Blood-borne markers of endothelial function
A blood sample was collected after an overnight fast. Plasma ICAM-1 and VACM-1 were analysed using commercially available ELISA kits (R&D Systems Inc., Minneapolis, MN, USA) at Hamilton Health Science Centre (Hamilton, Ontario, Canada). The intra-and inter-assay coefficients of variation for ICAM-1 and VACM-1 were 7.3% and 7.9%, and 2.0% and 3.6%, respectively.
Lifestyle intervention
The lifestyle intervention incorporated in this study contained four components: aerobic exercise, Mediterranean-style diet, activity diet prescription, and stage of change. The intervention was delivered by each subject's family physician. All subjects received all four components of our lifestyle modification and all components were commenced together.
Aerobic exercise: Each subject's exercise capacity and training intensity was determined using the STEP. Briefly, the STEP is a clinic-setting exercise, counselling and prescription tool that has been previously validated 21 and is endorsed by the College of Family Physicians of Canada as part of an accredited Continuing Health Education strategy to improve physical activity education among family physicians. Each participant's family physician administered the step test, which included stepping up and down two small (9.5 cm) steps at a comfortable pace 20 times. The stepping time (in seconds) and post-exercise heart rate were recorded, followed by conversion to predicted VO 2 max and an exercise heart rate based on 75% of predicted VO 2 max. 21 Following the test, participants were provided with a detailed exercise prescription based on the recommendation from the American College of Sports Medicine, 22 including frequency (most days of the week), intensity (moderate intensity), duration (either 30 minutes or three bouts of 10 minutes) and mode of exercise (aerobic exercise such as walking and cycling). Intensity of exercise during training was determined by palpating the radial artery pulse; participants were instructed to palpate the pulse for 10 seconds and multiply by six (for beats per minute).
Mediterranean-style diet: Participants were instructed to incorporate a Mediterranean-style diet characterised by an increased consumption of vegetables, legumes, fruits and whole grains, the use of olive oil/margarine as a main source of fat, and the intake of fish instead of red meat. 23 Moderate intake of red wine was allowed only with meals and within the recommended standard drink servings per day. Water is considered the most appropriate beverage. To optimise familiarisation with the diet and facilitate long-term adherence, during first 8 weeks, participants received one dinner meal per day (five meals per week) from the laboratory (prepared by the University of Western Ontario Food Services) as well as sample menus for breakfast and lunch. From week 9 onwards, subjects received only sample menus for all meals.
Activity diet prescription: This prescription was designed to link both the STEP and a Mediterranean-style diet together. Based on each participant's cardiovascular fitness (low/fair, average, and good/high) as determined by the STEP, family doctors determined the appropriate number of servings per each of the four food groups (grain products, fruits and vegetables, milk products, and meat and alternatives mainly coming from fish, poultry or legumes) that the participant should be eating per day.
Stage of change: Prochaska and DiClemente's 'stage of change' was used to assist participants to change their physical activity and nutritional behavior. 24 Briefly, by administering the Stage of Change Questionnaires for Physical Activity and a Mediterranean-style Diet and using the algorithms for Physical Activity and a Mediterraneanstyle Diet, family physicians determined what stage (precontemplation, contemplation, preparation, action, and maintenance) the participant was at for both physical activity and diet. They then counselled participants based on their stage for both physical activity and diet using appropriate stage-based counselling.
Statistical analysis
Data were expressed as means±SD, unless otherwise stated. Sample size was calculated with mean brachial artery diameter difference of 0.33 mm, 25 standard deviation of 0.25, α level of 0.05, and 80% power (two-sided tests), and a dropout rate estimated at 20%. A minimum of 12 subjects in each group was needed after consideration for loss to follow-up. Baseline data between participants without MS (MS-) and with MS (MS+) were tested using an independent-samples t-test and one-way ANOVA for continuous variables, and a χ 2 test for categorical variables. Variables with skewed distribution (HOMA and CRP) were log-transformed before statistical analysis. A repeated measures ANOVA was used to compare differences between baseline and following the 24 weeks of SNAC intervention. When a significant main effect was observed, a Bonferroni post hoc test was performed. For adjustment, age, gender, and/or baseline brachial artery diameter were used as covariates where appropriate. Pearson correlation analysis and multiple regression analysis were performed as a whole group to examine univariate and independent correlations of endothelial functions with MS components. To exclude the possibility of acute inflammation, we excluded the participants with CRP levels > 10 mg/L (n=6). Intention-to-treat analysis with the last-observation-carryforward method was used for those who did not complete the measurements following the 24 weeks of SNAC intervention (six MS-and six MS+ subjects). In most of the cases, the difficulties of scheduling for lab visit due to workrelated time constraints was the reason. Significance was set at p<0.05. All statistical analysis was performed using SPSS for Windows (version 14.0).
Results
Cross-sectional study
Selected baseline characteristics of the study participants are shown in Table 1 (part of these data have been published previously 26 ). Of 89 participants, 44 (20 male and 24 female, 53.5±9.3 years) were classified as MS-and 45 (20 male and 25 female, 53.4±9.9 years) as MS+. As expected, each component of MS was different between the groups: waist circumference, BP, fasting glucose levels, and triglyceride levels were all higher, and HDL cholesterol levels were lower in MS+ than MS-(all p<0.05, Table 1 ). Total cholesterol and LDL cholesterol levels showed no difference between the groups. Insulin, HgA 1 c, CRP and HOMA-IR were significantly higher in MS+ than in MS-(all p<0.05, Table 1 ).
The results of endothelial function (FMD and NMD) of the brachial artery, and blood-borne markers of endothelial function (ICAM-1 and VCAM-1) are shown in Figure 1 . While baseline brachial artery diameter tended to be greater in MS+ than in MS-(p=0.09), there were no differences in any outcomes between the groups. cIMT was similar between the groups (Table 1) . Subjects were then divided into four groups (those with one, two, three, or four and five MS components). There was no progressive increase in either outcome among groups (figure 2).
FMD was significantly inversely related with baseline brachial artery diameter (r=-0.47) and it remained independently associated with FMD (R 2 =0.21) on multiple regression analysis. ICAM-1 was significantly related with FG (r=0.22) but none appeared on multiple regression analysis. VCAM-1 was significantly related with age (r=0.28) and inversely related with DBP (r=-0.26). On multiple regression analysis, age, gender, and DBP were independently associated with VCAM-1 (R 2 =0.12). cIMT was significantly related with age (r=0.47) and SBP (r=0.28), and both parameters were independently associated with cIMT (R 2 =0.28) on multiple regression analysis. Results remained unchanged when MS was added into the multiple regression models as a dummy variable.
Intervention study
Of 52 participants in the intervention study, 26 were MS-(13 male and 13 female, 53.5±8.0 years) and 26 were MS+ (14 male and 12 female, 54.3±9.2 years). As was the case in the cross-sectional study, all the components of MS were different between the groups at baseline (all p<0.05, Table 2 ). In addition to higher insulin levels, HgA 1 c, CRP, HOMA-IR, and LDL cholesterol levels were also higher in MS+ than MS-at baseline (p<0.05). FMD was lower in MS-than MS+ at baseline (p<0.05, Figure 3 ) Table 2 . Effects of the 24-week lifestyle intervention on the subjects' characteristics Following the 24-week lifestyle intervention, improvements were observed in MS+ (waist circumference, BP, fasting glucose level, total cholesterol and LDL cholesterol levels, all p<0.05, Table 2 ). Baseline heart rate in MS+ was reduced following the intervention (p<0.05, Table 2 ). VO 2 max, estimated from metabolic equivalents, was significantly increased in both groups following the intervention (p<0.05, Table 2 ). Figure 3 shows the results of FMD, NMG, ICAM-1, and VCAM-1 following the 24-week lifestyle intervention. Contrary to the hypotheses, the 24-week lifestyle intervention had no impact on either endothelial function markers of atherosclerosis. This lack of improvement in these outcomes was in line with the lack of changes in CRP and HOMA-IR following the intervention (Table 2) . cIMT remained unchanged throughout the study period in either group (Table 2 ).
Discussion
The main finding of this study was that the presence of MS with HNBP and/or IGR does not diminish endothelial function assessed by FMD, ICAM-1, and VCAM-1. The second observation, that the 24-week lifestyle intervention prescribed by family physicians did not improve endothelial function despite the improvements in some of the MS components, is in line with the first observation that endothelial function is not diminished with the presence of MS.
Cross-sectional study
In this study, brachial artery FMD was similar between MSand MS+, as was the case in brachial artery NMD. Because MS-subjects in this study had at least one abnormality in MS components (none of them were free from any MS components) as well as the lack of trend with the number of MS components (Figure 2) , these results would suggest that in individuals at increased risk for CVD due to HNBP and/ or IGR, the presence of even one MS component may aggravate endothelial function. The lack of difference we observed in FMD between MS-and MS+ is in accordance with previous studies in older subjects, 9, 14 in subjects at increased risk for developing DM, 12, 13 and in subjects with untreated essential HT. 16 In contrast, some studies have found that the presence of MS was associated with reduced endothelial function. 10, 11, 15, 17 The discrepancy between those studies and our study may stem from the difference in methods used to assess endothelial function (peripheral microcirculation versus conduit artery in this study) and/or in subjects' inclusion criteria (HT, DM, and/or CVD versus none of them in this study). This disparity may, in turn, imply the powerful effect of CV risk factors such as HT and DM on endothelial function.
Similar to FMD, we found in this study that there were no differences in ICAM-1 or VCAM-1 between the groups. We also found that there was no progressive increase in ICAM-1 or VCAM-1 with the number of MS components (Figure 2 ). Our findings are in contrast with previous studies showing that the presence of MS is associated with increased levels of blood-borne markers of endothelial function. [27] [28] [29] [30] [31] [32] This disparity may be due to the inclusion of subjects with HT, DM, history of CVD, and/or the use of cardiovascular medications in those studies. Again, as in the case of FMD, this disparity may emphasise the strong impact that CV risk factors have on ICAM-1 and VCAM-1. Therefore, strategies to prevent the progression to HT from HNBP and the progression to DM from IGR, such as lifestyle modification, should add weight as a first-line therapy in clinical practice.
Intervention study
Although lifestyle modification is advocated as a first-line therapy for MS individuals to reduce the risk of atherosclerotic CVD, 8 and endothelial dysfunction may be an early stage in the atherosclerotic CVD continuum and therefore could potentially be used for a marker of atherosclerotic CVD risk, only a few studies have examined the effect of lifestyle modification on endothelial function in MS. In contrast to our hypothesis, endothelial function assessed by either brachial artery FMD or blood-borne markers of endothelial function (ICAM-1 and VCAM-1) remained unchanged despite the improvements in some MS components (waist circumference, SBP, and fasting glucose level) following the 24-week lifestyle intervention.
Individual components of lifestyle modification, such as aerobic exercise and diet, have been shown to improve endothelial function in MS subjects with or without concomitant improvements in MS components. [33] [34] [35] Additionally, two studies, to our best knowledge, have examined the effects of lifestyle modification as a whole on endothelial function in MS 36, 37 and have both shown an improvement in endothelial function (either brachial artery FMD and/or blood-borne markers of endothelial function) following the interventions. These results are in striking contrast to our results, which showed no improvement in endothelial function following lifestyle intervention. Although we have no definitive explanation for this discrepancy, possible explanations would be that (1) the subject's characteristics between previous studies and ours (inclusion of subjects with DM and/or CVD, more obese subjects, subjects' age, and definition for MS) were different, and that (2) the previous studies had more frequent follow-ups during their study periods than our study did. In particular, in Roberts and colleagues' study, 37 all food intake and exercise sessions were supervised during 21 days of the study period, and hence adherence to lifestyle modification was essentially 100%. In other words, because of the 'real-life' nature of our study (e.g. subjects performed exercise and mostly prepared food by themselves based on the prescriptions by their family doctors) compared with the 'lab-setting' nature of the previous studies, adherence to our lifestyle intervention in this study might have been sub-optimal, although exercise capacity increased (Table 2 ) and calorie intake reduced (data not shown) following the intervention. Another possible explanation would be that the lack of improvement in CRP and/or HOMA-IR in this study ( Table 2) might have accounted for the discrepancy with the previous studies 36, 37 since atherosclerosis has increasingly been recognised as an inflammatory disease, 38 with roles played by ICAM-1 and VCAM-1 in the initiation of atherosclerosis.
Study limitations
Several possible limitations of this study need to be mentioned. First, the relatively small sample size of this study might have resulted in a type 2 error. Second, the lack of time-control data and/or a control group might have impacted on the results observed in this study. We acknowledge that it is preferable to have a control group, but given the powerful effects of our lifestyle modification in subjects with MS in terms of the reduction in MS components as well as the lack of effect in subjects without MS, even if they were under the same intervention as MS subjects, we believe that the effects of our lifestyle modification are valid. Third, after we finished our data collection, Black and colleagues have found that the time to peak diameter following cuff deflation was significantly longer in older groups (80-83 seconds after cuff deflation) than that in young groups (50 seconds). 39 Based on their findings, although we have analysed FMD response according to the FMD guideline, 20 we might have missed the 'true' FMD response given the short time windows (45-75 seconds) of our measurements. Lastly, as we did not assess peripheral microvascular endothelial function, it might be possible that our lifestyle modification programme had an effect on that vascular function. Given the fact that the presence of MS has been shown to be associated with microvascular endothelial function in several cross-sectional studies, 10, 11, 14 this might have been the case. However, this seems unlikely based on the study by Hamdy et al. that, although unexpected, showed no effect of lifestyle intervention on forearm microcirculation. 36 
Perspectives
Although we were able to demonstrate the effectiveness of our lifestyle modification strategy to reduce MS components, we were unable to show an improvement in endothelial function in this study. Thus, we do not know if this lack of improvement in endothelial function in the face of improved MS risk factors would still elevate the risk for atherosclerotic CVD. However, because of the pivotal role that the endothelium plays in the development of atherosclerotic CVD, the lack of improvement in endothelial function despite the amelioration of MS components in this study may have an important clinical implication. An additional long-term follow-up study will be needed to determine whether the improvement in endothelial function is necessary in addition to the improvement in MS components to reduce the risk of atherosclerotic CVD. Furthermore, if the answer for this question calls for the improvements in both endothelial function and MS components, then another question arises in terms of how to improve endothelial function. Whether we should intensify lifestyle modification or move on to a pharmacological therapy remains to be answered.
Conclusions
The results of this study demonstrated that in subjects at increased risk for CVD due to HNBP and/or IGR, the presence of MS does not reduce endothelial function. In addition, our 24-week lifestyle modification programme did not result in an improvement in endothelial function in MS subjects despite the improvements in some MS components.
